New drug duo tested for Tough-to-Treat colon cancer
NCT ID NCT04963283
Summary
This study is testing whether a combination of two drugs, cabozantinib and nivolumab, can help control advanced colorectal cancer that has stopped responding to standard treatments. It will involve about 48 adults whose cancer has spread and is a specific type called microsatellite stable (MSS). The main goal is to see if the treatment can stop the cancer from growing for at least 16 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCHealth Family Medicine - Greeley
Greeley, Colorado, 80634, United States
-
UCHealth Harmony Campus
Fort Collins, Colorado, 80528, United States
-
UCHealth Medical Center of the Rockies
Loveland, Colorado, 80538, United States
-
UCHealth Memorial Hospital Central
Colorado Springs, Colorado, 80909, United States
-
University of Colorado Hospital
Aurora, Colorado, 80012, United States
Conditions
Explore the condition pages connected to this study.